Data / Form D filings / Climb Bio, Inc.
Climb Bio, Inc.: Form D filings
Climb Bio, Inc., a biotechnology company in Wellesley Hills, MA, filed 8 Form D notices with the SEC between 2019 and 2026. The latest, on May 4, 2026, reports $110.1 million sold of a $110.1 million offering to 22 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 20 WILLIAM STREET SUITE 145, Wellesley Hills, MA, 02481
- Phone
- 1-866-857-2596
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1768446
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 4, 2026 | New notice | $110,076,289 | $110,076,289 | 22 | Apr 29, 2026 | sec.gov | |
| Jul 2, 2024 | New notice | $119,999,986 | $119,999,986 | 8 | Jun 27, 2024 | sec.gov | |
| Jul 2, 2024 | New notice | $41,867,154 | $41,867,154 | 6 | Jun 27, 2024 | sec.gov | |
| May 28, 2021 | New notice | $59,999,987 | $59,999,987 | 9 | May 21, 2021 | sec.gov | |
| Nov 3, 2020 | New notice | $49,999,985 | $4,999,995 | $44,999,990 | 4 | Oct 16, 2020 | sec.gov |
| Oct 23, 2019 | New notice | $9,999,997 | $9,999,997 | 1 | Oct 10, 2019 | sec.gov | |
| Oct 23, 2019 | Amendment | $16,302,501 | $16,302,501 | 6 | Feb 4, 2019 | sec.gov | |
| Feb 19, 2019 | New notice | $12,240,000 | $12,240,000 | 4 | Feb 4, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Aoife Brennan | Executive Officer, Director | |
| Susan Altschuller | Executive Officer | |
| Perrin Wilson | Executive Officer | |
| Judith Dunn | Director | |
| Stephen Thomas | Director | |
| Douglas Williams | Director | |
| Alexander (Bo) Combo | Director | |
| Andrew Levin | Director | |
| Kimberlee Drapkin | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of May 4, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Climb Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.